Labcorp Holdings Inc.

Labcorp Holdings Inc., commonly known as Labcorp, is a global life sciences company headquartered in Burlington, North Carolina, U.S.. Its mission is to improve health and improve lives by providing innovative and comprehensive laboratory services that aid in diagnosis, healthcare decisions, and drug development. The company operates one of the largest clinical laboratory networks globally, serving clients in approximately 100 countries.

Labcorp operates through two primary segments: Diagnostics Laboratories and Biopharma Laboratory Services. The Diagnostics Laboratories segment offers a wide array of routine and specialty testing, including oncology, HIV, DNA, environmental, wellness, toxicology, and pain management, to physicians, hospitals, health systems, payers, employers, and patients. This segment is supported by an extensive network of patient service centers and in-office phlebotomists across the United States. The Biopharma Laboratory Services segment provides critical support for drug development, medical device, and diagnostic development to pharmaceutical, biotechnology, medical device, and diagnostic companies, encompassing central-lab and specialized testing services for clinical trials.

Adam H. Schechter serves as the Chairman, President, and CEO of Labcorp. In 2023, Labcorp spun off its clinical development business, Fortrea, to sharpen its focus on diagnostics and biopharma laboratory services. The company has recently launched MyLabcorp™, an AI-powered mobile app designed to help consumers understand lab results and track health trends. Labcorp reported strong first-quarter 2026 results and subsequently raised its full-year guidance. The company also recently agreed to a $35 million settlement in a class action lawsuit related to a 2018-2019 data breach involving a third-party collection agency.